SCHEMBL38532

SCHEMBL38532

c1ccc2c(c1)[N]ON2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9574491 0.65 ALOX5 (0.38)
SCHEMBL3255010 0.65 HTR5A (0.35)
SCHEMBL4007886 0.63
SCHEMBL134420 0.62
SCHEMBL3873063 0.60
SCHEMBL13819803 0.60 MAPT (0.43)
SCHEMBL240371 0.60 MAPT (0.43)
SCHEMBL6393157 0.60
SCHEMBL11622731 0.59 MEN1 (0.40)
SCHEMBL1449539 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2815 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118355015-A N- (5-substituted- [ (1, 3, 4-thiadiazole) or (thiazolyl) ]) (substituted) carboxamide compounds for inhibiting human polymerase θ and uses thereof 修复治疗公司 2024-07-16 CN claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
WO-2024104425-A1 KRAS INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 广东东阳光药业股份有限公司 2024-05-23 WO claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 US claimed
WO-2024056732-A1 PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2024-03-21 WO claimed
US-11912703-B2 6-azaindole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2024-02-27 US claimed
US-20240059703-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE AMGEN INC. 2024-02-22 US claimed
EP-4295910-A2 METHODS FOR TREATING MULTIPLE SCLEROSIS USING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITORY ACTIVITY Merck Patent GmbH (DE) 2023-12-27 EP claimed
WO-2023201014-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF N-ACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D VANDERBILT UNIVERSITY (US) 2023-10-19 WO claimed
EP-3728188-B1 ARYL AND HETEROARYL SUBSTITUTED INDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2023-10-11 EP claimed
EP-0253178-A1 Substituted 1,5-benzodiazepine compounds E.R. Squibb &amp; Sons, Inc. (US) 1988-01-20 EP claimed
US-4720499-A Treating blood vessel diseases with pyrido[4,3-b][1,6]naphthyridine-derivatives GODECKE AKTIENGESELLSCHAFT (DE) 1988-01-19 US claimed
US-4705785-A Substituted thiacycloalkeno (3,2-b) pyridines and pharmaceutical compositions and method of use ORTHO PHARMACEUTICAL CORPORATION (US) 1987-11-10 US claimed
EP-0241281-A2 Substituted thiacycloalkeno [3,2-b] pyridines, methods of preparation, compositions and method of use ORTHO PHARMACEUTICAL CORPORATION (US) 1987-10-14 EP claimed
US-4698341-A Use of 1,6-naphthyridinone derivatives in treating pulmonary thrombosis GODECKE AKTIENGESELLSCHAFT (DE) 1987-10-06 US claimed
US-4650797-A HYPOTENSIVES E. R. SQUIBB & SONS, INC. (US) 1987-03-17 US claimed
EP-0204317-A2 2-Thio or oxo-4-aryl or heterocyclo-1,5(2H)-pyrimidinedicarboxylic acid diesters and 3-acyl-5-pyrimidinecarboxylic acids and esters E.R. Squibb &amp; Sons, Inc. (US) 1986-12-10 EP claimed
CN-85106500-A Preparation 1, the method for 6-naphthyridines derivatives and medicinal group and thing 1986-07-23 CN claimed
EP-0177965-A2 Novel oxa- and thiadiazolyl derivatives and their use SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1986-04-16 EP claimed
EP-0163240-A2 Dihydroimidazo[1,2-a]pyrimidine derivatives, methods of preparing said compounds and pharmaceutical compositions constaining said compounds Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1985-12-04 EP claimed